View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Infection News

SPONSORED CONTENT
Save
SPONSORED CONTENT
March 30, 2022
2 min read
Save

Convalescent plasma reduces hospitalization risk in COVID-19

Convalescent plasma reduces hospitalization risk in COVID-19

Convalescent plasma, when administered within 9 days of symptom onset in patients with COVID-19, may reduce the risk for hospitalization, according to data published in The New England Journal of Medicine.

SPONSORED CONTENT
March 28, 2022
3 min read
Save

EULAR takes ‘precautionary position’ in support of third, booster COVID-19 vaccine doses

EULAR takes ‘precautionary position’ in support of third, booster COVID-19 vaccine doses

Citing a lack of available data and time, EULAR has taken a “precautionary position” in support of third and booster COVID-19 vaccine doses for patients with rheumatic and musculoskeletal diseases.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
March 28, 2022
4 min read
Save

Questions remain about mechanisms behind multisystem inflammatory syndrome in children

Questions remain about mechanisms behind multisystem inflammatory syndrome in children

PHOENIX — Although the CDC has presented a case definition of multisystem inflammatory syndrome in children, the COVID-19 complication continues to demand attention from researchers and providers alike.

SPONSORED CONTENT
March 25, 2022
1 min read
Save

Sotrovimab no longer authorized to treat COVID-19 in areas with high BA.2 frequency

Sotrovimab no longer authorized to treat COVID-19 in areas with high BA.2 frequency

The monoclonal antibody sotrovimab is no longer authorized by the FDA to treat COVID-19 in certain U.S. regions with high frequency of the omicron BA.2 subvariant.

SPONSORED CONTENT
March 15, 2022
2 min read
Save

Worse COVID-19 outcomes in lupus driven by demographics, untreated disease

Worse COVID-19 outcomes in lupus driven by demographics, untreated disease

Worse COVID-19 outcomes in patients with systemic lupus erythematosus are driven by comorbidities, demographics and untreated or active disease, according to data published in the Annals of the Rheumatic Diseases.

SPONSORED CONTENT
March 04, 2022
2 min read
Save

mRNA COVID-19 vaccines offer ‘quite encouraging’ long-term protection

mRNA COVID-19 vaccines offer ‘quite encouraging’ long-term protection

mRNA vaccines yielded not only strong short-term immune response against COVID-19, but also persistent immunity through at least 6 months, said a speaker at the Basic and Clinical Immunology for the Busy Clinician symposium.

SPONSORED CONTENT
March 03, 2022
2 min read
Save

COVID-19 unlikely to ‘fade away’ for the immunocompromised: ‘It’s good to have options’

COVID-19 unlikely to ‘fade away’ for the immunocompromised: ‘It’s good to have options’

COVID-19 fears and complications are likely to persist far into the future for immunocompromised individuals, a speaker noted at the Basic and Clinical Immunology for the Busy Clinician symposium.

SPONSORED CONTENT
March 02, 2022
2 min read
Save

‘Can we do any better?’: Biomarkers, more data needed to reduce cytokine storm mortality

‘Can we do any better?’: Biomarkers, more data needed to reduce cytokine storm mortality

A more nuanced understanding of COVID-19-related cytokine storm syndrome may hold the key to minimizing fatalities, noted a presenter at the Basic and Clinical Immunology for the Busy Clinician symposium.

SPONSORED CONTENT
March 02, 2022
3 min read
Save

Intersection of ‘highly heterogenous’ COVID-19, IMIDs remains ‘poorly understood’

Intersection of ‘highly heterogenous’ COVID-19, IMIDs remains ‘poorly understood’

Scientific advancement has yielded slow but steady progress in the understanding of COVID-19, particularly in patients with immune-mediated conditions, a presenter said at the Basic and Clinical Immunology for the Busy Clinician symposium.

SPONSORED CONTENT
March 01, 2022
3 min read
Save

Shifting ‘definition of fully vaccinated’ muddles COVID-19 vaccine efficacy data for IMIDs

Shifting ‘definition of fully vaccinated’ muddles COVID-19 vaccine efficacy data for IMIDs

An evolving definition of “fully vaccinated” has made it difficult to assess the utility and success of COVID-19 vaccines among patients with immune-mediated inflammatory diseases, a presenter noted here.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails